A Case of Lambert-Eaton Myasthenic Syndrome with Small-Cell Lung Cancer and Transient Increase in Anti-Acetylcholine-Receptor-Binding Antibody Titer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background Lambert-Eaton myasthenic syndrome (LEMS) is a presynaptic neuromuscular junction disorder that is most frequently associated with small-cell lung cancer (SCLC). The titers of antibodies against voltage-gated calcium channels are frequently increased in LEMS, but only rarely is titer of anti-acetylcholine-receptor-binding antibodies (AChR-abs) increased. Case Report A 57-year-old male was admitted to our hospital due to dry mouth and eyes and progressive proximal limb weakness of 2 months duration. The results of a repetitive nerve stimulation test disclosed all criteria for the electrophysiological LEMS pattern, and the patient’s AChRabs titer was 0.587 nmol/L. At a follow-up performed 5 years after successful treatment of SCLC and LEMS, his AChR-abs titer had decreased to 0.001 nmol/L. Conclusions We suggest that this was a case of transient pseudopositivity of AChR-abs in SCLC with LEMS.
Abstract
Background Lambert-Eaton myasthenic syndrome (LEMS) is a presynaptic neuromuscular junction disorder that is most frequently associated with small-cell lung cancer (SCLC). The titers of antibodies against voltage-gated calcium channels are frequently increased in LEMS, but only rarely is titer of anti-acetylcholine-receptor-binding antibodies (AChR-abs) increased. Case Report A 57-year-old male was admitted to our hospital due to dry mouth and eyes and progressive proximal limb weakness of 2 months duration. The results of a repetitive nerve stimulation test disclosed all criteria for the electrophysiological LEMS pattern, and the patient’s AChRabs titer was 0.587 nmol/L. At a follow-up performed 5 years after successful treatment of SCLC and LEMS, his AChR-abs titer had decreased to 0.001 nmol/L. Conclusions We suggest that this was a case of transient pseudopositivity of AChR-abs in SCLC with LEMS.
참고문헌 (10)
- Harper CM Jr, "Lambert-Eaton syndrome, In Myasthenia Gravis and Related Disorders. 2nd ed", pp.209~225 (2009), Humana Press
- Oh SJ, "Principles of Clinical Electromyography, Case Studies", pp.21~22 (1998), Williams & Wilkins
- Lee SA, "A case of remitted Lambert-Eaton myasthenic syndrome with small cell lung carcinoma following chemotherapy and radiotherapy.", J Korean Neurol Assoc, 10, pp.401~406 (1992)
- Katz JS, "Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome", Neurology, 50, pp.470~475 (1998)
- Newsom-Davis J, "Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients", J Neurol Neurosurg Psychiatry 1991, 54, pp.452~453 (1991)
- Taphoorn MJ, "A neuromuscular transmission disorder: combined myasthenia gravis and Lambert Eaton syndrome in one patient", J Neurol Neurosurg Psychiatry, 51, pp.880~882 (1988)
- Tabbaa MA, "Malignant thymoma with dysautonomia and disordered neuromuscular transmission", Arch Neurol, 43, pp.955~957 (1986)
- Oh SJ, "MG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence", Clin Neurophysiol, 116, pp.1167~1171 (2005)
- Fettel M, "Combined Eaton- Lambert syndrome and myasthenia gravis", Neurology, 28, pp.398~ (1978)
- Kaminski HJ, "Autoantibody testing in neuromuscular disorders, part II: neuromuscular junction, hyperexcitability, and muscle disorders", J Clin Neuromuscul Dis, 2, pp.96~105 (2000)